[
  {
    "ts": "2026-01-22T11:13:17+00:00",
    "headline": "BD and Ypsomed develop new version of Neopak XtraFlow syringe",
    "summary": "The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.",
    "url": "https://www.medicaldevice-network.com/news/bd-ypsomed-neopak-xtraflow-syringe/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "e79e74cf-3126-3838-990c-a5cd9f1af7d8",
      "content": {
        "id": "e79e74cf-3126-3838-990c-a5cd9f1af7d8",
        "contentType": "STORY",
        "title": "BD and Ypsomed develop new version of Neopak XtraFlow syringe",
        "description": "",
        "summary": "The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.",
        "pubDate": "2026-01-22T11:13:17Z",
        "displayTime": "2026-01-22T11:13:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/99d33c96c73e62fc76434c8259ac8243",
          "originalWidth": 1440,
          "originalHeight": 814,
          "caption": "BD is currently developing the Neopak XtraFlow 5.5ml glass prefillable syringe. Credit: BD / PRNewswire.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7rMS5UvsafcbsudU54tuzw--~B/aD04MTQ7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/99d33c96c73e62fc76434c8259ac8243.cf.webp",
              "width": 1440,
              "height": 814,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XOP6j9RS_7d_iakNH9nnBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/99d33c96c73e62fc76434c8259ac8243.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/bd-ypsomed-neopak-xtraflow-syringe/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-develop-version-neopak-111317183.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T15:43:00+00:00",
    "headline": "BD and Ypsomed Expand Partnership to Target Growing Biologics Market",
    "summary": "BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.",
    "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-target-154300462.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6bb3f5e3-6b9d-3fa4-8be9-8c17429b76c7",
      "content": {
        "id": "6bb3f5e3-6b9d-3fa4-8be9-8c17429b76c7",
        "contentType": "STORY",
        "title": "BD and Ypsomed Expand Partnership to Target Growing Biologics Market",
        "description": "",
        "summary": "BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.",
        "pubDate": "2026-01-22T15:43:00Z",
        "displayTime": "2026-01-22T15:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d",
          "originalWidth": 620,
          "originalHeight": 349,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pXgae5uF9D9MYxS_76Fk9Q--~B/aD0zNDk7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d.cf.webp",
              "width": 620,
              "height": 349,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e0rnH4SYvPBHzhUsRVMbdQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f505d3082c5c32dd86790426e65a15d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-target-154300462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-expand-partnership-target-154300462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "WST"
            },
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T21:15:12+00:00",
    "headline": "BD and Ypsomed’s Large‑Volume Biologic Autoinjector Collaboration Could Be A Game Changer For Becton Dickinson (BDX)",
    "summary": "BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 autoinjector, targeting large-volume, high-viscosity biologic self-injections. This move highlights BD's push deeper into large-volume subcutaneous drug delivery, aiming to make complex biologic treatments more practical for at-home use. Next, we’ll examine how BD’s expanded large-volume biologics platform...",
    "url": "https://finance.yahoo.com/news/bd-ypsomed-large-volume-biologic-211512480.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b5d536f9-6f2a-39cd-b4ba-1965352907a8",
      "content": {
        "id": "b5d536f9-6f2a-39cd-b4ba-1965352907a8",
        "contentType": "STORY",
        "title": "BD and Ypsomed’s Large‑Volume Biologic Autoinjector Collaboration Could Be A Game Changer For Becton Dickinson (BDX)",
        "description": "",
        "summary": "BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 autoinjector, targeting large-volume, high-viscosity biologic self-injections. This move highlights BD's push deeper into large-volume subcutaneous drug delivery, aiming to make complex biologic treatments more practical for at-home use. Next, we’ll examine how BD’s expanded large-volume biologics platform...",
        "pubDate": "2026-01-22T21:15:12Z",
        "displayTime": "2026-01-22T21:15:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b58c38c85f5024c1dadea82f36e4c65b",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2_x2Dbl5dfqz_CZ1IADbA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b58c38c85f5024c1dadea82f36e4c65b.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rONM9YSrYhkAF1NAw6yUUA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b58c38c85f5024c1dadea82f36e4c65b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-large-volume-biologic-211512480.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-ypsomed-large-volume-biologic-211512480.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]